Refractory and Relapsed B Cell Acute Leukemia
1 clinical trials · Condition
◉ Watch Refractory and Relapsed B Cell Acute Leukemia
| Record | Firm | Date |
|---|---|---|
| CD19/CD22-Dual-STAR-T for Patients With B Cell Acute Leukemia(B-ALL) (NCT04508842) | Hebei Yanda Ludaopei Hospital | 2020-10-10 |
Track Refractory and Relapsed B Cell Acute Leukemia automatically
Every clearance here is in the API, with alerts when new ones post.